mRNA |
momelotinib |
CTRPv2 |
pan-cancer |
AAC |
0.04 |
0.3 |
mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.3 |
mRNA |
VU0155056 |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.3 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.3 |
mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.3 |
mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.3 |
mRNA |
isoevodiamine |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.3 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.3 |
mRNA |
MLN2480 |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.3 |
mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
0.04 |
0.3 |